Keep up to date with what’s going on, where we are and other exciting news & views
Cello Health and BresMed join forces to support value demonstration and optimise patient access for new biopharma therapies
White paper by Jeffrey M. Bockman, PhD. Biotech and Breakthroughs in Immuno-Oncology
Join us at Cancer Progress, Virtual May 4-6 2021 ❝ Inspiring Cancer Progress through engaged stakeholder dialogue ❞
The biotech industry is in an exciting period of growth and innovation, the number of new products being registered continues to increase year on year, with a significant proportion of these being novel, first in class medicines.
Join us at the Pharmaceutical Management Science Association Virtual Meeting December 3-4, 2020 and visit our poster on Analogue Intelligence: Growing Both Players in a Duopoly Market, a case study from our growing practice in identifying and extracting learnings from analogues facing similar strategic challenges.
In this simple infographic we describe 15 drug innovations throughout recent history, from the first successful vaccine developed in the late 18th century to today’s personalised gene therapy treatments.
The acquisition of Cello Health provides the foundation for a new enterprise to enable healthcare and biopharmaceutical clients to maximize the value of their products.
The importance of medical communications within the pharmaceutical and healthcare sector should not be underestimated. Discover why and exactly what it is.
Find out exactly what the role of a healthcare consultant consists of, along with the necessary steps it takes to succeed in such a career
Happy MedComms Day 2020 from Cello Health’s Global Communications Team
Our Scientific and Creative Communications team is here to help adapt and drive your programmes to ensure seamless implementation.
These are some of the practical ways that the Business Insights and Analytics teams at Cello Health Insight in the US, UK and Germany are suggesting clients can continue to generate business insights as meeting customers face-to-face becomes more difficult.
